Ondansetron Viatris

Ondondansetron, the active ingredient in Ondansetron Viatris, is a 5-HT3 receptor antagonist presented as an intravenous solution for IV use. It helps prevent nausea and vomiting caused by chemotherapy, radiation therapy, and surgery in adult and pediatric patients. GNH USA supplies Ondansetron Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Ondansetron Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Ondansetron Viatris is a selective 5‑HT3 receptor antagonist used in the management of nausea and vomiting pathways associated with several medical treatments.

- Chemotherapy‑induced nausea and vomiting: Reduces the frequency and severity of acute and delayed episodes. - Radiation‑induced nausea and vomiting: Helps control the onset of vomiting during radiation sessions. - Post‑operative post‑operative post surgery recovery of vom vom v ​  ​  ​  ​  ​  ​  ​  ​  ​  ​ - Post‑operative  ​  ​  … -  …

This ​  …